Company Filing History:
1 out of 3 
1 out of 1,591 
Years Active: 2022
Title: Jon Helander: Innovator in Pharmaceutical Research
Introduction
Jon Helander is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of treatments for parasitic infections. His innovative work has led to the creation of a patent that addresses critical health challenges.
Latest Patents
Jon Helander holds 1 patent related to calcium-dependent protein kinase 1 (CDPK1). The patent, titled "CDPK1 inhibitors, compositions, and methods related thereto," focuses on inhibitors of CDPK1 and their pharmaceutical preparations. This invention is particularly relevant for treating parasitic infections, showcasing Helander's commitment to advancing medical science.
Career Highlights
Throughout his career, Jon has worked with prominent organizations, including Vyera Pharmaceuticals and Washington University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Jon has collaborated with notable colleagues such as Allen T. Hopper and L. David Sibley. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Jon Helander's contributions to pharmaceutical research, particularly through his patent on CDPK1 inhibitors, highlight his role as an innovator in the field. His work continues to influence the development of treatments for parasitic infections, underscoring the importance of innovation in healthcare.